FRA:GXI - Deutsche Boerse Ag - DE000A0LD6E6 - Common Stock - Currency: EUR
FRA:GXI (3/7/2025, 7:00:00 PM)
80.15
+0.05 (+0.06%)
The current stock price of GXI.DE is 80.15 EUR. In the past month the price increased by 1.2%. In the past year, price decreased by -23.52%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.07 | 182.78B | ||
DAP.DE | DANAHER CORP | 28.32 | 139.67B | ||
DIM.PA | SARTORIUS STEDIM BIOTECH | 55.77 | 19.00B | ||
56S1.DE | SARTORIUS STEDIM BIOTECH | 55.17 | 18.79B | ||
SRT3.DE | SARTORIUS AG-VORZUG | 46.36 | 17.15B | ||
SRT.DE | SARTORIUS AG | 37.17 | 13.75B | ||
ILU.DE | ILLUMINA INC | 34.19 | 12.24B | ||
ESF0.DE | EUROFINS SCIENTIFIC | 28.63 | 9.95B | ||
ERF.PA | EUROFINS SCIENTIFIC | 28.53 | 9.91B | ||
QIA.DE | QIAGEN N.V. | 18.07 | 7.89B | ||
1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 25.09 | 3.74B | ||
EVT.DE | EVOTEC SE | N/A | 2.34B |
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 12,012 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
GERRESHEIMER AG
Klaus-Bungert-Strasse 4
Dusseldorf NORDRHEIN-WESTFALEN DE
Employees: 11913
Company Website: https://www.gerresheimer.com/
Investor Relations: http://www.gerresheimer.com/en/company/investor-relations/reports
Phone: 49211618100
The current stock price of GXI.DE is 80.15 EUR. The price increased by 0.06% in the last trading session.
The exchange symbol of GERRESHEIMER AG is GXI and it is listed on the Deutsche Boerse Ag exchange.
GXI.DE stock is listed on the Deutsche Boerse Ag exchange.
24 analysts have analysed GXI.DE and the average price target is 103.85 EUR. This implies a price increase of 29.57% is expected in the next year compared to the current price of 80.15. Check the GERRESHEIMER AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GERRESHEIMER AG (GXI.DE) has a market capitalization of 2.77B EUR. This makes GXI.DE a Mid Cap stock.
GERRESHEIMER AG (GXI.DE) currently has 11913 employees.
GERRESHEIMER AG (GXI.DE) has a support level at 80.14 and a resistance level at 80.25. Check the full technical report for a detailed analysis of GXI.DE support and resistance levels.
The Revenue of GERRESHEIMER AG (GXI.DE) is expected to grow by 21.07% in the next year. Check the estimates tab for more information on the GXI.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GERRESHEIMER AG (GXI.DE) has a dividend yield of 1.56%. The yearly dividend amount is currently 1.32. Check the full fundamental report for a detailed analysis of GXI.DE dividend history, reliability and sustainability.
GERRESHEIMER AG (GXI.DE) will report earnings on 2025-04-08.
The PE ratio for GERRESHEIMER AG (GXI.DE) is 25.2. This is based on the reported non-GAAP earnings per share of 3.18 and the current share price of 80.15 EUR. Check the full fundamental report for a full analysis of the valuation metrics for GXI.DE.
ChartMill assigns a technical rating of 5 / 10 to GXI.DE. When comparing the yearly performance of all stocks, GXI.DE is a bad performer in the overall market: 85.67% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to GXI.DE. GXI.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months GXI.DE reported a non-GAAP Earnings per Share(EPS) of 3.18. The EPS decreased by -7.9% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.39% | ||
ROA | 2.88% | ||
ROE | 7.26% | ||
Debt/Equity | 0.61 |
ChartMill assigns a Buy % Consensus number of 84% to GXI.DE. The Buy consensus is the average rating of analysts ratings from 24 analysts.
For the next year, analysts expect an EPS growth of 20.03% and a revenue growth 21.07% for GXI.DE